Baekje: recommended by the National Institute of Health and Clinical Optimization in the UK for the treatment of adult patients with chronic lymphocytic leukemia
kkandkkg
发表于 2023-10-20 21:26:49
4044
0
0
On October 20th, Baekje announced that the National Institute of Health and Clinical Optimization (NICE) in the UK has released a final evaluation document recommending the company's product, Baekje&Co; Reg; Zebutinib capsules are used to treat adult patients who meet the following criteria for indication treatment: untreated chronic lymphoblastic leukemia (CLL) with 17p deficiency or TP53 mutation (high-risk) or untreated CLL without 17p deficiency or TP53 mutation, and are not suitable for receiving fludarabine cyclophosphamide rituximab (FCR) or bendamustine combined with rituximab (BR) treatment; And recurrent/refractory CLL.
Baiyue Ze& Reg; Zebutinib Capsules is a small molecule inhibitor of Bruton's tyrosine kinase (BTK) independently developed by the company. It is currently undergoing extensive clinical trials worldwide as a single drug and in combination with other therapies for the treatment of various B-cell malignancies. Due to the continuous synthesis of new BTK in the human body, Baiyue Ze& Reg; The design achieves complete and sustained inhibition of BTK protein by optimizing bioavailability, half-life, and selectivity.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Democratic tycoon pressure Biden to withdraw from election, new UK Prime Minister announces new cabinet member list | Global Markets
- UK regulatory agency launches investigation into Microsoft hiring former employees of Reflection AI
- Recruiting top AI experts raises competition concerns, UK launches merger investigation into Microsoft
- Microsoft technology malfunction affects the UK healthcare system, affecting both medical treatment and medication
- Disney will invest at least $5 billion in the UK and Europe over the next 5 years to produce movies and TV shows
- Amazon's $4 billion investment in AI startup Anthropic under investigation by UK regulators
- General Electric reportedly plans to acquire British startup Satavia
- General Electric reportedly plans to acquire British startup Satavia
- Microsoft's relationship with Reflection AI 'dodges' UK antitrust investigation
- The first batch of autopsy results for the British billionaire shipwreck case have been released: all four people had no water in their lungs and no signs of injury on their bodies. They suffocated to death before drowning
-
9月が終わり、映画・テレビ業界が暗躍している。最近、愛奇芸の創始者でCEOのGONG宇氏は、映画・テレビ業界が長短の変化、AIの変化、中国映画・テレビドラマの海外進出の変化の3つの変化を経験していると発表した。 ...
- 寒郁轩良
- 2 小时前
- 支持
- 反对
- 回复
- 收藏
-
8月のトヨタ自動車(ダイハツ自動車と日野自動車を除く、レクサスを含む)の世界生産台数は前年同月比11.2%減の709571台、世界販売台数は前年同月比3.1%減の826863台だった。 日本本土市場では、トヨタ自動車の8月 ...
- SOGO
- 前天 18:03
- 支持
- 反对
- 回复
- 收藏
-
ネットワーク状況監視サイトDownDetectorによると、オーディオストリーミングプラットフォームSpotifyは日曜日に約3時間にわたる障害を経験した後、正常に回復し、ピーク時には米国の4万人以上のユーザーに影響を与 ...
- hecgdge4
- 6 小时前
- 支持
- 反对
- 回复
- 收藏
-
百済神州(688235.SH)はA株の有名な革新薬企業で、2017-2024年上半期、同社の各期の研究開発投資はA株の化学製薬会社(申万二級)の中で最も高く、研究開発費用は合計600億元を超えた。 しかし、百済神州にとって ...
- wylz8473
- 昨天 18:36
- 支持
- 反对
- 回复
- 收藏